China Kicks Off Healthcare Reform Countrywide
This article was originally published in PharmAsia News
Executive Summary
China's 31 provinces and municipalities have set up their respective task force teams for healthcare reform, headed by each's deputy governor or principal official. Overall implementation plans and supplementary documents for the next three years are being formulated, with breakdowns in task definitions and estimated budgets. The healthcare reform is being rolled out nationwide: Heilongjiang has officially kicked off reform implementation opinions; Anhui, Zhejiang, Shaanxi and Sichuan have started pilots for integrated planning of new rural cooperative medical care systems on the city level; while Beijing, Shanghai, Tianjin, Hunan and Shandong are exploring the sale of essential drugs with zero profit margins in community healthcare institutions. (Click here for more - Chinese Language)
You may also be interested in...
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.